UNCY 주가 차트
UNCY 재무
Unicycive Therapeutics Inc
$7.02
1.73%
$0.11
종가: Apr 17, 16:00:00 GMT-4
$7.08
0.85%
$0.06
애프터마켓: Apr 17, 20:00:00 GMT-4
뒤로
Unicycive Therapeutics Inc (UNCY) 재무
주요 통계
이전 종가
$6.9
시가
$7.05
일일 범위
$6.87 - $7.08
52주 범위
$3.71 - $11
거래량
390.6K
평균 거래량
513.0K
배당수익률
--
EPS(TTM)
-2.97
시가총액
$178.6M
UNCY란 무엇인가요?
Unicycive Therapeutics, Inc. engages in the development of treatment for kidney diseases. The company is headquartered in Los Altos, California and currently employs 22 full-time employees. The company went IPO on 2021-06-17. The firm's lead drug candidate, oxylanthanum carbonate (OLC), is an investigational phosphate binding agent being developed for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis. Its second asset, UNI-494, is a patent-protected new chemical entity in clinical development for the treatment of conditions related to acute kidney injury.